Prostate,

Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study

Volunteers
Health Professionals

What is the purpose of this trial?

A prospective, multi-center, single-arm study, planned in 150 patients. The primary objective of the study is to further evaluate the safety and efficacy of a magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy system (TULSA-PRO) intended to ablate prostate tissue of patients with localized, organ-confined prostate cancer.

Trial with
Profound Medical Inc.
Ages
45 years - 80 years
Gender
Male only

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Kristin DeFrancesco

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Sandeep Arora, MBBS
Associate Professor of Radiology and Biomedical Imaging

Sub-Investigators

Last Updated
12/22/2022
Study HIC
#2000029224